UA48989C2 - Похідні 1-арилсульфоніл, арил(тіо)карбонілпіридазину, спосіб їх одержання, фармацевтична композиція та спосіб лікування - Google Patents

Похідні 1-арилсульфоніл, арил(тіо)карбонілпіридазину, спосіб їх одержання, фармацевтична композиція та спосіб лікування

Info

Publication number
UA48989C2
UA48989C2 UA98052267A UA98052267A UA48989C2 UA 48989 C2 UA48989 C2 UA 48989C2 UA 98052267 A UA98052267 A UA 98052267A UA 98052267 A UA98052267 A UA 98052267A UA 48989 C2 UA48989 C2 UA 48989C2
Authority
UA
Ukraine
Prior art keywords
derivatives
carbonylpyridazine
arylsulfonyl
thio
aryl
Prior art date
Application number
UA98052267A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Дональд У. Комбз
Original Assignee
Орто-Макнейл Фармасьютікел, Інк.
Орто-Макнейл Фармасьютикел, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орто-Макнейл Фармасьютікел, Інк., Орто-Макнейл Фармасьютикел, Инк. filed Critical Орто-Макнейл Фармасьютікел, Інк.
Publication of UA48989C2 publication Critical patent/UA48989C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36Benzo-cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UA98052267A 1995-11-06 1996-10-10 Похідні 1-арилсульфоніл, арил(тіо)карбонілпіридазину, спосіб їх одержання, фармацевтична композиція та спосіб лікування UA48989C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US790095P 1995-11-06 1995-11-06
PCT/US1996/016227 WO1997017332A1 (en) 1995-11-06 1996-10-10 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation

Publications (1)

Publication Number Publication Date
UA48989C2 true UA48989C2 (uk) 2002-09-16

Family

ID=21728709

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98052267A UA48989C2 (uk) 1995-11-06 1996-10-10 Похідні 1-арилсульфоніл, арил(тіо)карбонілпіридазину, спосіб їх одержання, фармацевтична композиція та спосіб лікування

Country Status (17)

Country Link
JP (1) JP2000501073A (ko)
KR (1) KR100360614B1 (ko)
CN (1) CN1110485C (ko)
AU (1) AU704507B2 (ko)
BR (1) BR9611407A (ko)
CZ (1) CZ286789B6 (ko)
HU (1) HU225162B1 (ko)
IL (1) IL124320A (ko)
MX (1) MX9803605A (ko)
NO (1) NO310460B1 (ko)
NZ (1) NZ319979A (ko)
PL (1) PL185618B1 (ko)
RU (1) RU2175969C2 (ko)
TW (1) TW460467B (ko)
UA (1) UA48989C2 (ko)
WO (1) WO1997017332A1 (ko)
ZA (1) ZA969298B (ko)

Also Published As

Publication number Publication date
IL124320A (en) 2001-10-31
AU7263796A (en) 1997-05-29
BR9611407A (pt) 1999-12-28
ZA969298B (en) 1998-05-05
NO310460B1 (no) 2001-07-09
NZ319979A (en) 1999-11-29
WO1997017332A1 (en) 1997-05-15
CN1207091A (zh) 1999-02-03
CZ286789B6 (en) 2000-07-12
MX9803605A (es) 1998-09-30
RU2175969C2 (ru) 2001-11-20
IL124320A0 (en) 1998-12-06
CN1110485C (zh) 2003-06-04
NO982030D0 (no) 1998-05-05
HUP0201305A2 (hu) 2002-12-28
PL185618B1 (pl) 2003-06-30
JP2000501073A (ja) 2000-02-02
PL326669A1 (en) 1998-10-12
HU225162B1 (en) 2006-07-28
TW460467B (en) 2001-10-21
NO982030L (no) 1998-06-23
KR100360614B1 (ko) 2003-06-02
AU704507B2 (en) 1999-04-22
KR19990067340A (ko) 1999-08-16
CZ138098A3 (cs) 1998-09-16
HUP0201305A3 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
ATE175353T1 (de) Verfahren und system zur empfängnisverhütung
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
NL300025I2 (nl) Combinatiedoseringsvorm voor vrouwen in de pre-menopauze.
AU2001273945A1 (en) 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
NZ262569A (en) Reducing bone loss by administration of 3,4-diphenylbenzo[b]pyran derivatives
MY151187A (en) Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
EA201200377A1 (ru) Способ пероральной контрацепции у женщин, способ управления нежелательными кровотечениями и предназначенная для применения в этих способах фармацевтическая упаковка
PT956024E (pt) Metodo contraceptivo oral monofasico e estojo ("kit") compreendendo uma combinacao de uma progestina e estrogenio
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
BG105804A (en) 16-hydroxyestratrienes as selective acting estrogens
UA48989C2 (uk) Похідні 1-арилсульфоніл, арил(тіо)карбонілпіридазину, спосіб їх одержання, фармацевтична композиція та спосіб лікування
IL99123A0 (en) Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives
GR1000989B (el) Μεθοδος παρασκευης συνθεσεως για θεραπεια οστεοπορωσης και ορμονικης ανισορροπιας.
EP0902025A3 (en) Benzothiophenes for treatment of estrogen related conditions
BR0014952A (pt) Medicamento contraceptivo e seu modo de preparação
NZ330603A (en) Hyaluronic acid derivatives used as cervical ripening agents
EP1025098A4 (en) BENTZOTHIOPHENE
PL352029A1 (en) 14-beta-h-sterols, pharmaceutical compositions containing these sterols and use of these derivatives for obtaining drugs to regulate meioses
HUP9903310A3 (en) Indole derivatives for the treatment of osteoporosis pharmaceutical compositions containing them, process for producing them and their medical use